BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 14604889)

  • 1. Down-regulation of c-myc and Cyclin D1 genes by antisense oligodeoxy nucleotides inhibits the expression of E2F1 and in vitro growth of HepG2 and Morris 5123 liver cancer cells.
    Simile MM; De Miglio MR; Muroni MR; Frau M; Asara G; Serra S; Muntoni MD; Seddaiu MA; Daino L; Feo F; Pascale RM
    Carcinogenesis; 2004 Mar; 25(3):333-41. PubMed ID: 14604889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell cycle deregulation in liver lesions of rats with and without genetic predisposition to hepatocarcinogenesis.
    Pascale RM; Simile MM; De Miglio MR; Muroni MR; Calvisi DF; Asara G; Casabona D; Frau M; Seddaiu MA; Feo F
    Hepatology; 2002 Jun; 35(6):1341-50. PubMed ID: 12029619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell cycle basis for the onset and progression of c-Myc-induced, TGFalpha-enhanced mouse mammary gland carcinogenesis.
    Liao DJ; Natarajan G; Deming SL; Jamerson MH; Johnson M; Chepko G; Dickson RB
    Oncogene; 2000 Mar; 19(10):1307-17. PubMed ID: 10713672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inhibitory effect of cyclin D1 antisense cDNA on human hepatocarcinoma cell line HepG2].
    Xiao ZY; Chen XP; Huang ZY
    Zhonghua Gan Zang Bing Za Zhi; 2005 Oct; 13(10):768-71. PubMed ID: 16248951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A modest reduction in c-myc expression has minimal effects on cell growth and apoptosis but dramatically reduces susceptibility to Ras and Raf transformation.
    Bazarov AV; Adachi S; Li SF; Mateyak MK; Wei S; Sedivy JM
    Cancer Res; 2001 Feb; 61(3):1178-86. PubMed ID: 11221849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption of Rb/E2F pathway results in increased cyclooxygenase-2 expression and activity in prostate epithelial cells.
    Davis JN; McCabe MT; Hayward SW; Park JM; Day ML
    Cancer Res; 2005 May; 65(9):3633-42. PubMed ID: 15867358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of in vitro myogenic differentiation by cellular transcription factor E2F1.
    Wang J; Helin K; Jin P; Nadal-Ginard B
    Cell Growth Differ; 1995 Oct; 6(10):1299-306. PubMed ID: 8845307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of HPV oncoproteins and cellular factors in maintenance of hTERT expression in cervical carcinoma cells.
    Jeong Seo E; Jung Kim H; Jae Lee C; Tae Kang H; Seong Hwang E
    Gynecol Oncol; 2004 Jul; 94(1):40-7. PubMed ID: 15262117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A DNA microarray screen for genes involved in c-MYC and N-MYC oncogenesis in human tumors.
    Schuldiner O; Benvenisty N
    Oncogene; 2001 Aug; 20(36):4984-94. PubMed ID: 11526483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different regulation of c-Myc- and E2F-1-induced apoptosis during the ongoing cell cycle.
    Hengstschläger M; Hölzl G; Hengstschläger-Ottnad E
    Oncogene; 1999 Jan; 18(3):843-8. PubMed ID: 9989838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation.
    Ozaki I; Zhang H; Mizuta T; Ide Y; Eguchi Y; Yasutake T; Sakamaki T; Pestell RG; Yamamoto K
    Clin Cancer Res; 2007 Apr; 13(7):2236-45. PubMed ID: 17404108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bortezomib arrests the proliferation of hepatocellular carcinoma cells HepG2 and JHH6 by differentially affecting E2F1, p21 and p27 levels.
    Baiz D; Pozzato G; Dapas B; Farra R; Scaggiante B; Grassi M; Uxa L; Giansante C; Zennaro C; Guarnieri G; Grassi G
    Biochimie; 2009 Mar; 91(3):373-82. PubMed ID: 19041685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vitamin C reverses benzo (a) pyrene-induced cell cycle changes by E2F pathway].
    Gao A; Liu BC; Shen FH; Du HJ; Huang CS; Jia XW; You BR; Ye M
    Zhonghua Yu Fang Yi Xue Za Zhi; 2006 Mar; 40(2):79-83. PubMed ID: 16640900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leptin-induced growth of human ZR-75-1 breast cancer cells is associated with up-regulation of cyclin D1 and c-Myc and down-regulation of tumor suppressor p53 and p21WAF1/CIP1.
    Chen C; Chang YC; Liu CL; Chang KJ; Guo IC
    Breast Cancer Res Treat; 2006 Jul; 98(2):121-32. PubMed ID: 16752079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-Myc-induced chemosensitization is mediated by suppression of cyclin D1 expression and nuclear factor-kappa B activity in pancreatic cancer cells.
    Biliran H; Banerjee S; Thakur A; Sarkar FH; Bollig A; Ahmed F; Wu J; Sun Y; Liao JD
    Clin Cancer Res; 2007 May; 13(9):2811-21. PubMed ID: 17473215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of signal transducer and activator of transcription 3 expression using vector-based small interfering RNAs suppresses growth of human prostate tumor in vivo.
    Gao L; Zhang L; Hu J; Li F; Shao Y; Zhao D; Kalvakolanu DV; Kopecko DJ; Zhao X; Xu DQ
    Clin Cancer Res; 2005 Sep; 11(17):6333-41. PubMed ID: 16144938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of cyclin expression and cell cycle progression in breast epithelial cells by the helix-loop-helix protein Id1.
    Swarbrick A; Akerfeldt MC; Lee CS; Sergio CM; Caldon CE; Hunter LJ; Sutherland RL; Musgrove EA
    Oncogene; 2005 Jan; 24(3):381-9. PubMed ID: 15489884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A chenodeoxycholic derivative, HS-1200, induces apoptosis and cell cycle modulation via Egr-1 gene expression control on human hepatoma cells.
    Park SE; Lee SW; Hossain MA; Kim MY; Kim MN; Ahn EY; Park YC; Suh H; Kim GY; Choi YH; Kim ND
    Cancer Lett; 2008 Oct; 270(1):77-86. PubMed ID: 18554781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of c-myc expression by an antisense approach under Cre/loxP switching induces apoptosis in human liver cancer cells.
    Ebinuma H; Saito H; Kosuga M; Wakabayashi K; Saito Y; Takagi T; Nakamoto N; Okuyama T; Ishii H
    J Cell Physiol; 2001 Jul; 188(1):56-66. PubMed ID: 11382922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual apoptotic effect of Xrel3 c-Rel/NF-kappaB homolog in human cervical cancer cells.
    Shehata M; Shehata M; Shehata F; Pater A
    Cell Biol Int; 2004; 28(12):895-904. PubMed ID: 15566959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.